Iberogast

Iberogast, the active ingredient in Iberogast, is a herbal preparation presented as a oral liquid for oral use. It is used to relieve functional dyspepsia, irritable bowel syndrome and other gastrointestinal discomfort in adults.

GNH USA supplies Iberogast as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iberogast is employed to manage functional gastrointestinal disorders.

Functional dyspepsia: reduces upper abdominal discomfort, bloating and early satiety. Irritable bowel syndrome: alleviates abdominal pain, cramping and irregular bowel habits. Gastrointestinal discomfort: eases nausea, heartburn, gas‑related symptoms and mild indigestion.

Iberogast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Mild gastrointestinal upset such as transient nausea or diarrhea. - Altered taste perception or unpleasant after‑taste. - Skin redness or mild rash at the site of contact. - Headache. - Dizziness.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reactions. - Significant elevation of liver enzymes. - Acute pancreatitis. - Severe skin reactions including Stevens‑Johnson syndrome. - Eosinophilic gastroenteritis. - Unexplained bleeding or bruising.

Before using Iberogast, consider the following precautions.

Pregnancy: safety not established; consult a healthcare professional before use. Breastfeeding: insufficient data; use only if clearly needed. Drug interactions: review all concomitant medications, especially other gastrointestinal agents. Allergy: avoid if known hypersensitivity to any herbal component of the formulation. Medical conditions: exercise caution in patients with severe liver disease. Store at ambient temperature: keep in the original container, protect from moisture and light.

Iberogast may interact with other medicines; monitor accordingly.

Major Interactions (Avoid): - Cytochrome P450 inhibitors: may increase plasma levels of certain herbal constituents. - Anticholinergic drugs: additive reduction of gastrointestinal motility. - Anticoagulants: potential increased bleeding risk due to herbal effects.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may alter absorption of some extracts. - Antidiarrheal agents: overlapping mechanisms may affect efficacy. - Other herbal supplements containing similar ingredients: risk of additive effects.